Top Section/Ad
Top Section/Ad
Most recent
Shareholders sell down holdings in AutoStore and Orsted, as shipping company opens books ahead of Athens parallel listing
Deeply discounted financing allows embattled iron ore miner to restart Ukrainian production and shares to resume trading
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Food systems company’s largest shareholder raises €324m after shares rise on strong results and buyback
More articles/Ad
More articles/Ad
More articles
-
Volatility has returned to equity capital markets, derailing indices and making new capital raising much more difficult. ECM deals can still offer investors a way to outperform, but when markets are tough, their risk appetite shrivels. Many political shocks could hurt in 2019, starting with Brexit and a global trade war. But overshadowing all this is the fear that a more profound pessimism has returned to stalk equity markets, after their long upward decade. Sam Kerr reports. -
Santhera Pharmaceuticals, the Swiss speciality pharmaceuticals company, has launched a Sfr77m fundraising following the release of its latest earnings statement on Wednesday morning.
-
Nicholas Chia has left OCBC to join CLSA as the Citic Securities-owned brokerage looks to build out its southeast Asia equity capital markets franchise.
-
Doosan Bobcat’s largest shareholder has bagged W141.9bn ($126.5m) after trimming its stake in the South Korean heavy equipment maker.
-
Zur Rose, the Swiss online pharmacy, has completed its Sfr200m ($200.8m) at-market rights issue to fund the acquisition of a German e-commerce platform, following the sale of a rump placement on Wednesday evening.
-
UK equity capital markets are feeling the pain from Brexit, with volumes from the country this autumn at one of the lowest levels in recent history.
